# Intranasal Midazolam for Treatment of Anxiety in Children Undergoing Suturing in the Pediatric Emergency Department

> **NCT02618772** · PHASE4 · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 79 (actual)

## Conditions studied

- Anxiety
- Lacerations

## Interventions

- **DRUG:** Midazolam
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02618772
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2015-03
- **Final completion:** 2015-11
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2016-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02618772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02618772, "Intranasal Midazolam for Treatment of Anxiety in Children Undergoing Suturing in the Pediatric Emergency Department". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02618772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*